John Vasilakos is the Global Head of MTS Business Development and Senior Research Immunologist at Kindeva Drug Delivery. His previous industry roles include Senior Research Immunologist and Business Development of TLR Ligands at 3M Drug Delivery Solutions Division and Vice-President of Immunology at Biothera. He has spent more than 25 years in the biopharmaceutical industry, focusing on vaccines and immunotherapy for cancer and chronic viral diseases. He holds a PhD from the University of Cincinnati School of Medicine (OH, US).